查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1987082

不孕症治療服務市場規模、佔有率、趨勢和預測：按不孕症病因、治療方法、服務、最終用戶和地區分類，2026-2034 年

Fertility Services Market Size, Share, Trends and Forecast by Cause of Infertility, Procedure, Service, End-User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2025年全球生育服務市場規模為519億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以12.15%的複合年成長率成長，到2034年達到1502億美元。目前，亞太地區是該市場的主要驅動力，預計到2025年將佔據30%的市場。推動這一成長的因素包括人口基數不斷擴大、生活方式相關不孕症和延遲生育率上升、收入水平提高使得更多人能夠獲得生殖醫學服務，以及專業生育診所網路不斷擴展。所有這些因素都促進了亞太地區生育服務市場佔有率的擴大。

已開發國家和開發中國家不孕症病例的不斷增加，推動了生育服務市場的成長，促使更多個人和夫婦尋求生育服務。由於生育年齡延遲、生活方式相關的健康問題以及生殖系統疾病病例的增加等因素，全球患者數量正在穩步成長。卵子冷凍和代孕等生育服務的接受度不斷提高，以及政府強制推行的保險覆蓋，使得人們更容易獲得生育服務。生育診所的增加、冷凍保存技術和基因篩檢的進步，以及人們健康意識的提高，都是推動生育服務市場發展的因素。

由於多種因素，美國正崛起為生育服務市場的重要區域。憑藉世界一流的醫療保健基礎設施、訓練有素的生殖內分泌專家以及完善的認證生育中心網路，美國擁有全球最先進、最成熟的生殖健康生態系統之一。 2025年10月，美國政府宣布了舉措，旨在降低體外受精（IVF）藥物的成本並擴大生育保險的覆蓋範圍，包括獨立的IVF福利和藥物折扣。專業專業延遲生育的趨勢、同性伴侶建立家庭數量的增加以及與生活方式和環境因素相關的生育率上升，都推動了市場對生育服務的巨大需求。此外，雇主提供的生育福利也日益普遍，越來越多的公司將生育保險納入員工健康保險計劃，以吸引和留住人才。

不孕症治療服務市場趨勢

全球不孕不育率上升

不孕症盛行率的上升是推動生育治療服務市場發展的關鍵因素。受孕延遲、久坐的生活方式、環境污染以及生殖健康問題發病率的增加，都加劇了全球不孕症負擔。世界衛生組織（世衛組織）於2025年11月發布了首個全球不孕症指南，指出約六分之一的育齡婦女受到不孕症的影響，凸顯了不孕症作為一項重大公共衛生問題的嚴重性，以及擴大預防、診斷和治療服務覆蓋範圍的必要性。隨著許多國家的性生活頻率和生育率的上升，對輔助生殖技術的需求持續強勁。為了應對這一問題，各國政府和衛生組織正在擴大宣傳宣傳活動，並為治療津貼。不孕症作為一種合法疾病的日益被認可，使得尋求治療變得更加普遍，擴大了患者群體，並確保了長期的市場需求。

生殖醫學的技術進步

快速的技術進步正在改變生殖醫學，使輔助生殖技術更有效率和個人化。胚胎著床前遺傳學檢測、胚胎選擇演算法、延時成像和冷凍保存技術的進步顯著提高了手術成功率。人工智慧 (AI) 在胚胎評估中的應用，使得臨床決策更加數據驅動，從而改善了患者的治療效果。 2025 年 9 月，Fairtility 的人工智慧胚胎評估平台 CHLOE 獲得美國食品藥物管理局 (FDA) 的核准。這是美國首個核准的同種異體設備，能夠使臨床體外受精 (IVF) 中的胚胎評估更加客觀和數據驅動。小型化的實驗室系統和自動化工具提高了手術的準確性，同時降低了營運成本。新的卵巢刺激通訊協定和改良的培養基也進一步提高了出生率。這些發展正在推動醫療和生物技術領域的投資成長，隨著患者對實證、技術先進的生殖解決方案的需求日益成長，這些發展對生育服務的市場前景產生了積極影響。

社會接受度和意識的提高

文化態度的轉變正在對全球生育服務的擴張起到變革性作用。生育治療曾一度飽受污名化，如今已被廣泛認可為合法且必要的醫療干預措施。媒體通報和公開討論使生殖健康議題不再是人們關注的焦點，鼓勵個人和夫妻積極尋求幫助。 2025年3月，英國健康與胚胎管理局（HFEA）報告稱，約72%的生育患者對其最近一次治療感到滿意。這反映出人們對生育治療的信心增強，以及對治療結果更開放的態度。單親家庭的興起和LGBTQ+家庭的壯大正在擴大生育服務的用戶群體，並使需求模式更加多元化。醫療服務提供者和支持團體持續進行有針對性的宣傳活動，普及生殖健康和生育力保存方面的知識。生育服務市場的這些趨勢反映了社會的根本性變革，並支撐著全球對全面生育照護日益成長的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章：引言

第5章：全球不孕症治療服務市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：依不孕不育原因分類
  • 市場區隔：按治療類型
  • 市場區隔：依服務分類
  • 市場區隔：依最終用戶分類
  • 市場區隔：按地區
  • 市場預測

第6章 市場區隔：依不孕症病因分類

  • 男性不孕
  • 女性不孕症

第7章 市場區隔：依治療方式分類

  • 體外卵細胞質內單一精蟲顯微注射術（IVF with ICSI）
  • 代孕
  • 體外受精（卵細胞質內單一精蟲顯微注射術）
  • 子宮內人工授精（IUI）
  • 其他

第8章 市場區隔：依服務分類

  • 非活體捐贈者
  • 冷凍非捐贈者
  • 卵子和胚胎的保存
  • 活體捐贈者
  • 冷凍捐贈者

第9章 市場區隔：依最終用戶分類

  • 不孕症治療診所
  • 醫院
  • 外科中心
  • 臨床研究機構
  • 冷凍保存庫

第10章 市場區隔：依地區分類

  • 歐洲
  • 北美洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Instituto Bernabeu Group
    • INVO Bioscience, Inc.
    • Monash IVF Group
    • Apollo Hospitals Enterprise Ltd.
    • CARE Fertility Group Ltd.
    • Carolinas Fertility Institute
    • Genea Limited
    • The Cooper Companies, Inc.
    • Virtus Health Group
    • Vitrolife Sweden AB
    • The Johns Hopkins Health System Corporation
    • Medicover AB（publ）
    • OvaScience, Inc.
    • Progyny, Inc.
    • Xytex Corporation
Product Code: SR112026A1547

The global fertility services market size was valued at USD 51.9 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 150.2 Billion by 2034, exhibiting a CAGR of 12.15% from 2026-2034. Asia Pacific currently dominates the market, holding a market share of 30% in 2025. The region benefits from its expanding population base, increasing rates of infertility attributed to lifestyle-related factors and delayed family planning, rising income levels facilitating access to reproductive healthcare, and a growing network of specialized fertility clinics, all contributing to the Asia Pacific fertility services market share.

The fertility services market growth is driven by the rising cases of infertility in both developed and developing nations, thus encouraging more individuals and couples to turn to fertility services. The rising number of late pregnancies, lifestyle-related health problems, and the growing number of cases of reproductive disorders are steadily increasing the global patient base. The growing acceptance of fertility services such as egg freezing and surrogacy, as well as government insurance mandates, are making fertility services more accessible. The growing number of fertility clinics, advancements in cryopreservation and genetic screening, and growing awareness about healthcare are all factors that are driving the fertility services market.

The United States has emerged as a major region in the fertility services market owing to many factors. The country hosts one of the most advanced and well-established reproductive healthcare ecosystems globally, supported by world-class medical infrastructure, highly trained reproductive endocrinologists, and a robust network of accredited fertility centers. In October 2025, the U.S. government announced a policy initiative to lower the cost of in-vitro fertilization (IVF) medications and expand access to fertility coverage, including standalone IVF benefits and discounted drugs. Significant demand is driven by the growing trend of delayed parenthood among working professionals, increasing same-sex couple family formation, and rising infertility rates linked to lifestyle and environmental factors. Additionally, employer-sponsored fertility benefits have become increasingly commonplace, with a growing number of corporations including fertility coverage in employee health plans to attract and retain talent.

FERTILITY SERVICES MARKET TRENDS:

Rising Prevalence of Infertility Worldwide

The rising prevalence of infertility is a critical driver shaping the fertility services market. Postponement of childbearing, sedentary lifestyles, environmental pollutant exposure, and growing incidences of reproductive health disorders are collectively expanding the infertility burden across global populations. According to the World Health Organization's first global guideline on infertility released in November 2025, infertility affects about one in six people of reproductive age, highlighting its scale as a major public health issue and need for wider access to prevention, diagnosis, and treatment. Both male and female infertility rates have trended upward in numerous countries, sustaining consistent demand for medically assisted reproduction. In response to the issue, governments and health organizations have expanded awareness campaigns and subsidized treatments. The increasing acceptance of infertility as a legitimate medical condition has normalized seeking treatment, which has expanded the pool of patients and ensured long-term market demand.

Technological Advancements in Reproductive Medicine

Rapid technological innovation is transforming reproductive medicine, making assisted reproduction more effective and personalized. Advancements in preimplantation genetic testing, embryo selection algorithms, time-lapse imaging, and cryopreservation methods have significantly improved procedural success rates. Artificial intelligence applications in embryo evaluation enable more data-driven clinical decisions, enhancing patient outcomes. In September 2025, Fairtility received FDA clearance for its CHLOE AI-powered embryo assessment platform, the first such device approved in the United States, enabling more objective, data-driven embryo evaluation in clinical IVF practice. Miniaturized laboratory systems and automation tools are improving procedural precision while reducing operational costs. Novel ovarian stimulation protocols and improved culture media are further contributing to higher live birth rates. These developments are attracting growing healthcare and biotechnology investments, positively influencing the fertility services market outlook as patients increasingly prefer evidence-based, technologically advanced reproductive care solutions.

Growing Social Acceptance and Awareness

Shifting cultural attitudes are playing a transformative role in expanding the utilization of fertility services globally. Historically stigmatized, fertility treatments are now widely regarded as legitimate and medically necessary interventions. Media representation and open public discourse have normalized reproductive health challenges, encouraging individuals and couples to proactively seek assistance. In March 2025, the UK's Human Fertilisation and Embryology Authority (HFEA) reported that nearly 72% of fertility patients were satisfied with their most recent treatment, reflecting growing comfort with fertility care and openness about outcomes. The rise of single parenthood by choice and LGBTQ+ family formation has broadened the demographic of fertility services users, diversifying demand patterns. Healthcare providers and advocacy organizations continue launching targeted awareness initiatives around reproductive health and fertility preservation options. These evolving fertility services market trends reflect a fundamental societal shift, sustaining growing demand for comprehensive fertility interventions worldwide.

FERTILITY SERVICES INDUSTRY SEGMENTATION:

Analysis by Cause of Infertility:

  • Male Infertility
  • Female Infertility

Female infertility contributes 62% to the market share. Female infertility can be described as a broad spectrum of reproductive disorders that impact a woman's ability to reproduce or maintain a pregnancy to term. The leading causes of female infertility include ovulatory dysfunction, tubal factor, uterine abnormalities, and conditions such as polycystic ovary syndrome, endometriosis, and premature ovarian failure. Compared to male infertility, the diagnostic and therapeutic strategies for female infertility are more complex and subtle, requiring a variety of therapies from hormonal to surgical and reproductive assistive therapies. The clinical complexity and associated burden of female reproductive disorders contribute significantly to the total demand for fertility care, from ovulation induction to in vitro fertilization and egg donation. Moreover, egg freezing for fertility preservation has emerged as a new market that has been expanding rapidly over the last few years, as women are now empowered to control their reproductive life plan in the context of delayed reproduction.

Analysis by Procedure:

  • In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
  • Surrogacy
  • In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI)
  • Intrauterine Insemination (IUI)
  • Others

In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI) currently dominates the market with a share of 35%. This technique involves the injection of a single sperm directly into a mature egg, providing a highly targeted and effective approach for couples struggling with severe male factor infertility or unexplained infertility after failed conventional IVF cycles. Due to its proven efficacy and high fertilization success rates, combined with its compatibility with preimplantation genetic testing, IVF with ICSI has become the method of choice in the most advanced clinics worldwide for the selection of chromosomally normal embryos prior to uterine transfer. Sperm selection by MAC (magnetic-activated cell sorting) technique is used in men who have poor sperm morphology and/or low sperm counts. It is also useful in cases when fertilization fails in dietary procedures. Constant enhancement of laboratory techniques, improvements in ovarian stimulation regimens and the increased expertise of reproductive practitioners together are responsible for the success of ICSI, thereby making it the leader in the fertility techniques market.

Analysis by Service:

  • Fresh Non-Donor
  • Frozen Non-Donor
  • Egg and Embryo Banking
  • Fresh Donor
  • Frozen Donor

Fresh non-donor dominates the market, with a share of 30%. Fresh non-donor services involve the use of a patient's own freshly retrieved eggs and partner-provided sperm to create embryos for immediate transfer, making it the most widely utilized fertility service pathway. This approach is preferred by couples seeking a biologically connected parenthood option without reliance on donor gametes, and it remains the first-line treatment option in most fertility clinics globally. The fresh non-donor cycle is favored for its natural approach, immediate embryo transfer capability, and the avoidance of complexities associated with cryopreservation protocols in uncomplicated cases. Its widespread adoption across both public and private fertility settings, combined with high patient familiarity and physician comfort with the procedure, sustains its leading market position. The growing volume of IVF and ICSI cycles being performed globally, along with favorable clinical guidelines recommending fresh transfers in appropriate candidates, reinforces the prominence of this segment within the broader fertility services market forecast.

Analysis by End-User:

  • Fertility Clinics
  • Hospitals
  • Surgical Centres
  • Clinical Research Institutes
  • Cryobanks

Fertility clinics represent the leading segment, with a market share of 41%. These are specially designed facilities that are equipped with the latest reproductive laboratories, diagnostic facilities, and staff specifically trained to deal with infertility evaluation and management. Fertility clinics provide an integrated service delivery that encompasses consultation, hormonal analysis, ultrasound follow-up, egg retrieval procedures, embryology laboratory facilities, embryo transfer, and follow-up care in a single setting. The concentration of expertise, infrastructure, and patient focus makes fertility clinics the point of choice for patients seeking assisted reproductive technology services. In November 2025, INVO Fertility, Inc. announced plans to acquire Indiana-based Family Beginnings, expanding its national clinic network to meet rising patient demand and reflecting ongoing consolidation in the fertility sector. Many leading clinics have also established partnerships with genetic testing laboratories and cryobanks, enabling seamless integration of preimplantation genetic testing and fertility preservation into their service offerings.

Regional Analysis:

  • Europe
  • North America
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Asia Pacific, accounting for 30% of the share, enjoys the leading position in the market. The region's dominance is underpinned by several interconnected factors that collectively drive robust demand for fertility services across its diverse economies. The region includes some of the most populated countries in the world, such as China, India, Japan, South Korea, and Australia, each with unique fertility service demand patterns influenced by demographic factors, healthcare policies, and cultural perceptions of assisted reproduction. The rapidly aging population in the East Asian economies, combined with the high prevalence of infertility in South Asian markets, provides a wide patient base. Government-backed fertility assistance initiatives, such as IVF cycle subsidies in Japan, Australia, and South Korea, have greatly enhanced the accessibility and affordability of fertility services. At the same time, the growing number of technologically advanced fertility centers and the rising medical tourism presence in countries like India and Thailand continue to enhance the fertility services capacity in the Asia Pacific region, making it the largest regional contributor to the global market.

KEY REGIONAL TAKEAWAYS:

North America Fertility Services Market Analysis

North America represents one of the most advanced and well-established regional markets for fertility services, driven by a combination of demographic shifts, technological leadership, and favorable policy environments. The region benefits from a high concentration of accredited fertility centers, sophisticated reproductive laboratory infrastructure, and a robust network of highly trained reproductive specialists dedicated to delivering comprehensive assisted reproductive care. Rising infertility prevalence linked to delayed childbearing, lifestyle-related health conditions, and increasing family formation among diverse demographics, including same-sex couples and single individuals, continues to expand the patient base significantly. Employer-sponsored fertility benefits and state-level insurance mandates have substantially improved treatment affordability and accessibility across broader population segments. The strong culture of innovation in reproductive medicine, combined with growing patient awareness, increasing investment in fertility technologies, and expanding clinic networks, reinforces North America's prominent and sustained position within the global fertility services market.

United States Fertility Services Market Analysis

The United States is the most advanced and mature fertility services market in the world, with a high level of concentration of accredited fertility centers, a complex fertility services ecosystem, and a well-established regulatory framework led by professional associations such as the Society for Assisted Reproductive Technology. The demand for fertility services in the United States is fueled by a combination of demographic and social trends, including the pervasive trend of delayed childbearing, the high prevalence of infertility in the general population, and the growing trend of family formation among same-sex couples. The availability of fertility benefits through employers has increased substantially, with an increasing number of Fortune 500 companies offering comprehensive fertility benefits as part of their employees' health benefits, making fertility treatments that were hitherto cost-prohibitive more accessible to patients. State-based insurance mandates requiring coverage for fertility diagnostics and treatments have also widened the pool of eligible patients and made fertility treatments more accessible. The culture of innovation in the United States reproductive medicine industry, along with high patient engagement, makes the United States the largest and most vibrant national fertility services market in the world.

Europe Fertility Services Market Analysis

Europe represents the second largest regional market for fertility services, supported by well-funded public healthcare systems in many member states and a long-established tradition of reproductive medicine research and clinical excellence. Countries such as Spain, Denmark, the Czech Republic, and the United Kingdom have positioned themselves as leading destinations for fertility treatments, attracting significant volumes of patients from both within Europe and internationally through medical tourism. In February 2025, Poland reinstated public funding for in-vitro fertilization (IVF), leading to its first IVF-conceived babies under the scheme and making all EU member states provide some level of public fertility treatment funding. The European fertility services landscape is characterized by a combination of publicly funded fertility treatment cycles and a thriving private clinic sector, with the balance varying considerably across different national healthcare systems. Regulatory frameworks governing donor anonymity, surrogacy, and embryo storage policies differ significantly across European jurisdictions, influencing patient cross-border movements and clinic specialization strategies.

Asia Pacific Fertility Services Market Analysis

The Asia Pacific has turned out to be the most rapidly growing market for fertility care. The growing demand for fertility care in the Asia Pacific is fueled by a number of factors, including the demographic trend, advancements in the healthcare infrastructure, and the changing attitudes of society towards fertility care. The rising incidence of infertility, due to late marriage and childbearing, environmental conditions, and lifestyle-related health issues, is increasing the patient base in the East and South Asian markets. Government support in Japan and South Korea to provide subsidies for fertility care is actively working to overcome the cost constraints and fuel the demand. The rapid development of a network of fertility clinics and the rising trend of medical tourism in India and Thailand is further strengthening the competitiveness of the Asia Pacific market in the global arena.

Latin America Fertility Services Market Analysis

Latin America is a steadily expanding market for fertility care, fueled by the growing awareness of infertility, private investments in the healthcare sector, and favorable medical tourism trends. Brazil, Mexico, Colombia, and Argentina have become the hubs for fertility care in Latin America, providing affordable fertility treatments that lure local as well as foreign patients. The rising levels of urbanization, changing lifestyles, and postponement of parenthood are contributing to the rising incidence of infertility in Latin America, which in turn is fueling the demand for various fertility treatments. Although fertility care is not easily accessible in rural and lower socioeconomic settings due to cost considerations, the increasing development of private fertility centers in major cities is slowly bridging the gap in fertility treatment accessibility in Latin America.

Middle East and Africa Fertility Services Market Analysis

The Middle East and Africa represent an emerging market for fertility services, characterized by significant growth potential amid evolving healthcare infrastructure and increasing social awareness of reproductive health. The high rates of infertility in the region, coupled with the cultural and religious values of family expansion, create a latent demand for fertility services. Countries such as the United Arab Emirates, Saudi Arabia, South Africa, and Israel have developed the infrastructure for advanced fertility clinics to attract patients from the region. Despite regulatory and cultural constraints that limit certain procedures such as surrogacy and gamete donation in some jurisdictions, the market continues to expand steadily, driven by rising healthcare spending, improving medical capabilities, and a growing population of treatment-seeking individuals.

COMPETITIVE LANDSCAPE:

The global fertility services market is moderately fragmented in terms of competitive intensity, with a combination of large integrated healthcare conglomerates, specialized fertility chain clinics, and standalone fertility clinics operating in different geographies. Market players are increasingly resorting to consolidation strategies, with private equity-funded acquisitions and mergers fueling the creation of large fertility clinic chains operating across several countries. Market leaders are diversifying their service offerings by investing in advanced reproductive technologies, lab infrastructure, and specialization, while at the same time expanding geographically to capitalize on high-growth fertility markets. Partnerships with genetic testing firms, embryo cryopreservation experts, and digital health platforms are also aiding players in providing more holistic and tech-enabled fertility solutions. Pricing competition and visibility of patient outcomes are reshaping the competitive environment, with patients increasingly using success rate data and reviews to select their fertility service provider. The industry is also facing challenges such as differences in regulations in various markets, a shortage of skilled reproductive specialists, and limited reimbursement in most regions.

The report provides a comprehensive analysis of the competitive landscape in the fertility services market with detailed profiles of all major companies, including:

  • Instituto Bernabeu Group
  • INVO Bioscience, Inc.
  • Monash IVF Group
  • Apollo Hospitals Enterprise Ltd.
  • CARE Fertility Group Ltd.
  • Carolinas Fertility Institute
  • Genea Limited
  • The Cooper Companies, Inc.
  • Virtus Health Group
  • Vitrolife Sweden AB
  • The Johns Hopkins Health System Corporation
  • Medicover AB (publ)
  • OvaScience, Inc.
  • Progyny, Inc.
  • Xytex Corporation

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the fertility services market?

2. What is the future outlook of the fertility services market?

3. What are the key factors driving the fertility services market?

4. Which region accounts for the largest fertility services market share?

5. Which are the leading companies in the global fertility services market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Fertility Services Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Cause of Infertility
  • 5.5 Market Breakup by Procedure
  • 5.6 Market Breakup by Service
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Cause of Infertility

  • 6.1 Male Infertility
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Female Infertility
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Procedure

  • 7.1 In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Surrogacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Intrauterine Insemination (IUI)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Service

  • 8.1 Fresh Non-Donor
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Frozen Non-Donor
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Egg and Embryo Banking
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Fresh Donor
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Frozen Donor
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Fertility Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Surgical Centres
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Clinical Research Institutes
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Cryobanks
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 Europe
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 North America
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Instituto Bernabeu Group
    • 15.3.2 INVO Bioscience, Inc.
    • 15.3.3 Monash IVF Group
    • 15.3.4 Apollo Hospitals Enterprise Ltd.
    • 15.3.5 CARE Fertility Group Ltd.
    • 15.3.6 Carolinas Fertility Institute
    • 15.3.7 Genea Limited
    • 15.3.8 The Cooper Companies, Inc.
    • 15.3.9 Virtus Health Group
    • 15.3.10 Vitrolife Sweden AB
    • 15.3.11 The Johns Hopkins Health System Corporation
    • 15.3.12 Medicover AB (publ)
    • 15.3.13 OvaScience, Inc.
    • 15.3.14 Progyny, Inc.
    • 15.3.15 Xytex Corporation

List of Figures

  • Figure 1: Global: Fertility Services Market: Major Drivers and Challenges
  • Figure 2: Global: Fertility Services Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Fertility Services Market: Breakup by Cause of Infertility (in %), 2025
  • Figure 4: Global: Fertility Services Market: Breakup by Procedure (in %), 2025
  • Figure 5: Global: Fertility Services Market: Breakup by Service (in %), 2025
  • Figure 6: Global: Fertility Services Market: Breakup by End-User (in %), 2025
  • Figure 7: Global: Fertility Services Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Fertility Services Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 9: Global: Fertility Services Industry: SWOT Analysis
  • Figure 10: Global: Fertility Services Industry: Value Chain Analysis
  • Figure 11: Global: Fertility Services Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Fertility Services (Male Infertility) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 13: Global: Fertility Services (Male Infertility) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 14: Global: Fertility Services (Female Infertility) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 15: Global: Fertility Services (Female Infertility) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 16: Global: Fertility Services (In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 17: Global: Fertility Services (In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 18: Global: Fertility Services (Surrogacy) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 19: Global: Fertility Services (Surrogacy) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 20: Global: Fertility Services In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI) ) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 21: Global: Fertility Services (In Vitro Fertilization Without Intracytoplasmic Sperm Injection (IVF without ICSI) ) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 22: Global: Fertility Services (Intrauterine Insemination (IUI)) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 23: Global: Fertility Services (Intrauterine Insemination (IUI)) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 24: Global: Fertility Services (Other Procedures) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 25: Global: Fertility Services (Other Procedures) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 26: Global: Fertility Services (Fresh Non-Donor) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 27: Global: Fertility Services (Fresh Non-Donor) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 28: Global: Fertility Services (Frozen Non-Donor) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 29: Global: Fertility Services (Frozen Non-Donor) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 30: Global: Fertility Services (Egg and Embryo Banking) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 31: Global: Fertility Services (Egg and Embryo Banking) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 32: Global: Fertility Services (Fresh Donor) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 33: Global: Fertility Services (Fresh Donor) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 34: Global: Fertility Services (Frozen Donor) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 35: Global: Fertility Services (Frozen Donor) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 36: Global: Fertility Services (Fertility Clinics) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 37: Global: Fertility Services (Fertility Clinics) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 38: Global: Fertility Services (Hospitals) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 39: Global: Fertility Services (Hospitals) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 40: Global: Fertility Services (Surgical Centres) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 41: Global: Fertility Services (Surgical Centres) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 42: Global: Fertility Services (Clinical Research Institutes) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 43: Global: Fertility Services (Clinical Research Institutes) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 44: Global: Fertility Services (Cryobanks) Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 45: Global: Fertility Services (Cryobanks) Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 46: Europe: Fertility Services Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 47: Europe: Fertility Services Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 48: North America: Fertility Services Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 49: North America: Fertility Services Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 50: Asia Pacific: Fertility Services Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 51: Asia Pacific: Fertility Services Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 52: Middle East and Africa: Fertility Services Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 53: Middle East and Africa: Fertility Services Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 54: Latin America: Fertility Services Market: Sales Value (in Billion USD), 2020 & 2025
  • Figure 55: Latin America: Fertility Services Market Forecast: Sales Value (in Billion USD), 2026-2034

List of Tables

  • Table 1: Global: Fertility Services Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Fertility Services Market Forecast: Breakup by Cause of Infertility (in Billion USD), 2026-2034
  • Table 3: Global: Fertility Services Market Forecast: Breakup by Procedure (in Billion USD), 2026-2034
  • Table 4: Global: Fertility Services Market Forecast: Breakup by Service (in Billion USD), 2026-2034
  • Table 5: Global: Fertility Services Market Forecast: Breakup by End-User (in Billion USD), 2026-2034
  • Table 6: Global: Fertility Services Market Forecast: Breakup by Region (in Billion USD), 2026-2034
  • Table 7: Global: Fertility Services Market: Competitive Structure
  • Table 8: Global: Fertility Services Market: Key Players